Selected research
Industry Research
Health and Medical Microalgae Industry Research Report 2026
Market perspective
The global Health and Medical Microalgae market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Health and Medical Microalgae is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Health and Medical Microalgae is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Health and Medical Microalgae include DIC Corporation, Koninkliijke DSM NV, Roquette Frères, Sun chlorella, Cellana LLC, Fuji Chemical Industries Co., Ltd., Yunnan Green-A-Bio-engineering Co Ltd, Cyanotech Corporation and BASF SE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Health and Medical Microalgae market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Health and Medical Microalgae Market by Company
DIC Corporation
Koninkliijke DSM NV
Roquette Frères
Sun chlorella
Cellana LLC
Fuji Chemical Industries Co., Ltd.
Yunnan Green-A-Bio-engineering Co Ltd
Cyanotech Corporation
BASF SE
Parry Nutraceuticals
Beijing Gingko Group
Health and Medical Microalgae Segment by Type
Spirulina
Chlorella
Dunaliella
Aphanizomenon
Haematococcus
Crypthecodinium
Schizochytrium
Euglena
Nannochloropsis
Others
Health and Medical Microalgae Segment by Application
Nutraceuticals and Dietary Supplements
Pharmaceuticals
Health and Medical Microalgae Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health and Medical Microalgae market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Health and Medical Microalgae and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health and Medical Microalgae.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Health and Medical Microalgae manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Health and Medical Microalgae by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Health and Medical Microalgae in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spirulina
- Chlorella
- Dunaliella
- Aphanizomenon
- Haematococcus
- Crypthecodinium
- Schizochytrium
- Euglena
- Nannochloropsis
- Others
Applications
- Nutraceuticals and Dietary Supplements
- Pharmaceuticals
Companies covered
- DIC Corporation
- Koninkliijke DSM NV
- Roquette Frères
- Sun chlorella
- Cellana LLC
- Fuji Chemical Industries Co., Ltd.
- Yunnan Green-A-Bio-engineering Co Ltd
- Cyanotech Corporation
- BASF SE
- Parry Nutraceuticals
- Beijing Gingko Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Health and Medical Microalgae Market Size (2021-2032)
- 2.2.2 Global Health and Medical Microalgae Sales (2021-2032)
- 2.2.3 Global Health and Medical Microalgae Market Average Price (2021-2032)
- 2.3 Health and Medical Microalgae by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Spirulina
- 2.3.3 Chlorella
- 2.3.4 Dunaliella
- 2.3.5 Aphanizomenon
- 2.3.6 Haematococcus
- 2.3.7 Crypthecodinium
- 2.3.8 Schizochytrium
- 2.3.9 Euglena
- 2.3.10 Nannochloropsis
- 2.3.11 Others
- 2.4 Health and Medical Microalgae by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Nutraceuticals and Dietary Supplements
- 2.4.3 Pharmaceuticals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Health and Medical Microalgae Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Health and Medical Microalgae Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Health and Medical Microalgae Revenue of Manufacturers (2021-2026)
- 3.4 Global Health and Medical Microalgae Average Price by Manufacturers (2021-2026)
- 3.5 Global Health and Medical Microalgae Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Health and Medical Microalgae, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Health and Medical Microalgae, Product Type & Application
- 3.8 Global Manufacturers of Health and Medical Microalgae, Established Date
- 3.9 Global Health and Medical Microalgae Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DIC Corporation
- 4.1.1 DIC Corporation Company Information
- 4.1.2 DIC Corporation Business Overview
- 4.1.3 DIC Corporation Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DIC Corporation Health and Medical Microalgae Product Portfolio
- 4.1.5 DIC Corporation Recent Developments
- 4.2 Koninkliijke DSM NV
- 4.2.1 Koninkliijke DSM NV Company Information
- 4.2.2 Koninkliijke DSM NV Business Overview
- 4.2.3 Koninkliijke DSM NV Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Koninkliijke DSM NV Health and Medical Microalgae Product Portfolio
- 4.2.5 Koninkliijke DSM NV Recent Developments
- 4.3 Roquette Frères
- 4.3.1 Roquette Frères Company Information
- 4.3.2 Roquette Frères Business Overview
- 4.3.3 Roquette Frères Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roquette Frères Health and Medical Microalgae Product Portfolio
- 4.3.5 Roquette Frères Recent Developments
- 4.4 Sun chlorella
- 4.4.1 Sun chlorella Company Information
- 4.4.2 Sun chlorella Business Overview
- 4.4.3 Sun chlorella Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sun chlorella Health and Medical Microalgae Product Portfolio
- 4.4.5 Sun chlorella Recent Developments
- 4.5 Cellana LLC
- 4.5.1 Cellana LLC Company Information
- 4.5.2 Cellana LLC Business Overview
- 4.5.3 Cellana LLC Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cellana LLC Health and Medical Microalgae Product Portfolio
- 4.5.5 Cellana LLC Recent Developments
- 4.6 Fuji Chemical Industries Co., Ltd.
- 4.6.1 Fuji Chemical Industries Co., Ltd. Company Information
- 4.6.2 Fuji Chemical Industries Co., Ltd. Business Overview
- 4.6.3 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Product Portfolio
- 4.6.5 Fuji Chemical Industries Co., Ltd. Recent Developments
- 4.7 Yunnan Green-A-Bio-engineering Co Ltd
- 4.7.1 Yunnan Green-A-Bio-engineering Co Ltd Company Information
- 4.7.2 Yunnan Green-A-Bio-engineering Co Ltd Business Overview
- 4.7.3 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Product Portfolio
- 4.7.5 Yunnan Green-A-Bio-engineering Co Ltd Recent Developments
- 4.8 Cyanotech Corporation
- 4.8.1 Cyanotech Corporation Company Information
- 4.8.2 Cyanotech Corporation Business Overview
- 4.8.3 Cyanotech Corporation Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cyanotech Corporation Health and Medical Microalgae Product Portfolio
- 4.8.5 Cyanotech Corporation Recent Developments
- 4.9 BASF SE
- 4.9.1 BASF SE Company Information
- 4.9.2 BASF SE Business Overview
- 4.9.3 BASF SE Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BASF SE Health and Medical Microalgae Product Portfolio
- 4.9.5 BASF SE Recent Developments
- 4.10 Parry Nutraceuticals
- 4.10.1 Parry Nutraceuticals Company Information
- 4.10.2 Parry Nutraceuticals Business Overview
- 4.10.3 Parry Nutraceuticals Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Parry Nutraceuticals Health and Medical Microalgae Product Portfolio
- 4.10.5 Parry Nutraceuticals Recent Developments
- 4.11 Beijing Gingko Group
- 4.11.1 Beijing Gingko Group Company Information
- 4.11.2 Beijing Gingko Group Business Overview
- 4.11.3 Beijing Gingko Group Health and Medical Microalgae Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Beijing Gingko Group Health and Medical Microalgae Product Portfolio
- 4.11.5 Beijing Gingko Group Recent Developments
5 Global Health and Medical Microalgae Market Scenario by Region
- 5.1 Global Health and Medical Microalgae Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Health and Medical Microalgae Sales by Region: 2021-2032
- 5.2.1 Global Health and Medical Microalgae Sales by Region: 2021-2026
- 5.2.2 Global Health and Medical Microalgae Sales by Region: 2027-2032
- 5.3 Global Health and Medical Microalgae Revenue by Region: 2021-2032
- 5.3.1 Global Health and Medical Microalgae Revenue by Region: 2021-2026
- 5.3.2 Global Health and Medical Microalgae Revenue by Region: 2027-2032
- 5.4 North America Health and Medical Microalgae Market Facts & Figures by Country
- 5.4.1 North America Health and Medical Microalgae Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Health and Medical Microalgae Sales by Country (2021-2032)
- 5.4.3 North America Health and Medical Microalgae Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Health and Medical Microalgae Market Facts & Figures by Country
- 5.5.1 Europe Health and Medical Microalgae Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Health and Medical Microalgae Sales by Country (2021-2032)
- 5.5.3 Europe Health and Medical Microalgae Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Health and Medical Microalgae Market Facts & Figures by Country
- 5.6.1 Asia Pacific Health and Medical Microalgae Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Health and Medical Microalgae Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Health and Medical Microalgae Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Health and Medical Microalgae Market Facts & Figures by Country
- 5.7.1 South America Health and Medical Microalgae Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Health and Medical Microalgae Sales by Country (2021-2032)
- 5.7.3 South America Health and Medical Microalgae Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Health and Medical Microalgae Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Health and Medical Microalgae Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Health and Medical Microalgae Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Health and Medical Microalgae Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Health and Medical Microalgae Sales by Type (2021-2032)
- 6.1.1 Global Health and Medical Microalgae Sales by Type (2021-2032) & (t)
- 6.1.2 Global Health and Medical Microalgae Sales Market Share by Type (2021-2032)
- 6.2 Global Health and Medical Microalgae Revenue by Type (2021-2032)
- 6.2.1 Global Health and Medical Microalgae Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Health and Medical Microalgae Revenue Market Share by Type (2021-2032)
- 6.3 Global Health and Medical Microalgae Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Health and Medical Microalgae Sales by Application (2021-2032)
- 7.1.1 Global Health and Medical Microalgae Sales by Application (2021-2032) & (t)
- 7.1.2 Global Health and Medical Microalgae Sales Market Share by Application (2021-2032)
- 7.2 Global Health and Medical Microalgae Revenue by Application (2021-2032)
- 7.2.1 Global Health and Medical Microalgae Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Health and Medical Microalgae Revenue Market Share by Application (2021-2032)
- 7.3 Global Health and Medical Microalgae Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Health and Medical Microalgae Value Chain Analysis
- 8.1.1 Health and Medical Microalgae Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Health and Medical Microalgae Production Mode & Process
- 8.2 Health and Medical Microalgae Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Health and Medical Microalgae Distributors
- 8.2.3 Health and Medical Microalgae Customers
9 Global Health and Medical Microalgae Analyzing Market Dynamics
- 9.1 Health and Medical Microalgae Industry Trends
- 9.2 Health and Medical Microalgae Industry Drivers
- 9.3 Health and Medical Microalgae Industry Opportunities and Challenges
- 9.4 Health and Medical Microalgae Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst